Tinidazole was approved by the FDA in May 2004 for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.

Mild Clostridium difficile infection (CDI ... clinical deterioration and place on therapy immediately if this occurs. Treatment for an initial episode and a first recurrence of CDI: If oral ...

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality rates, especially in vulnerable populations. CDI ...

diff to respond to treatment and for diarrhea to clear ... administered a probiotic supplement showed a lower risk of ...

A real-world study of patients with Clostridioides difficile infection (CDI) in Australia over 10 years shows that fecal ...

A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative therapeutic strategies to antibiotics and fecal transplant. To investigate whether ...

New research reveals that specialized gut bacteria convert bile acids into powerful healing compounds, offering hope for ...

Although this treatment is relatively new it has had ... NICE have found that the evidence supporting FMT for recurrent Clostridium difficile infection is sufficient for the procedure to be ...

Experts have met to discuss the risks and knowledge gaps around Clostridium botulinum and Clostridium perfringens. At a Food and Agriculture Organization ...

difficile treatment. Oral FZ002 is a live yeast genetically modified to express a tetraspecific anti-toxin for C. difficile in the gastrointestinal (GI) tract. FZ002 is a first-in-class multi ...